BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30020198)

  • 1. The many faces of CD8+ T cells in atherosclerosis.
    van Duijn J; Kuiper J; Slütter B
    Curr Opin Lipidol; 2018 Oct; 29(5):411-416. PubMed ID: 30020198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and pathogenic roles of CD8
    Cochain C; Zernecke A
    Basic Res Cardiol; 2016 Nov; 111(6):71. PubMed ID: 27783202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Schäfer S; Zernecke A
    Cells; 2020 Dec; 10(1):. PubMed ID: 33383733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
    Qiu MK; Wang SC; Dai YX; Wang SQ; Ou JM; Quan ZW
    PLoS One; 2015; 10(6):e0128523. PubMed ID: 26035207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for CD8 T-cell migration into the human arterial wall.
    Gewaltig J; Kummer M; Koella C; Cathomas G; Biedermann BC
    Hum Pathol; 2008 Dec; 39(12):1756-62. PubMed ID: 18706675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis.
    van Dijk RA; Duinisveld AJ; Schaapherder AF; Mulder-Stapel A; Hamming JF; Kuiper J; de Boer OJ; van der Wal AC; Kolodgie FD; Virmani R; Lindeman JH
    J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
    Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Two Faces of Interleukin-17A in Atherosclerosis.
    Akhavanpoor M; Akhavanpoor H; Gleissner CA; Wangler S; Doesch AO; Katus HA; Erbel C
    Curr Drug Targets; 2017; 18(7):863-873. PubMed ID: 28034277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
    Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
    Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD39 identifies a microenvironment-specific anti-inflammatory CD8
    van Duijn J; van Elsas M; Benne N; Depuydt M; Wezel A; Smeets H; Bot I; Jiskoot W; Kuiper J; Slütter B
    Atherosclerosis; 2019 Jun; 285():71-78. PubMed ID: 31048101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Disorder in Atherosclerotic Cardiovascular Disease - Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers.
    Neupane R; Jin X; Sasaki T; Li X; Murohara T; Cheng XW
    Circ J; 2019 Jun; 83(7):1431-1438. PubMed ID: 31092769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells in atherogenesis: for better or for worse?
    Robertson AK; Hansson GK
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2421-32. PubMed ID: 16973967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation.
    Xu MM; Murphy PA; Vella AT
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1354-H1365. PubMed ID: 30925075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pleiotropic role of interleukin-17 in atherosclerosis.
    Allam G; Abdel-Moneim A; Gaber AM
    Biomed Pharmacother; 2018 Oct; 106():1412-1418. PubMed ID: 30119214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia induces T cell expansion in humanized immune mice.
    Proto JD; Doran AC; Subramanian M; Wang H; Zhang M; Sozen E; Rymond CC; Kuriakose G; D'Agati V; Winchester R; Sykes M; Yang YG; Tabas I
    J Clin Invest; 2018 Jun; 128(6):2370-2375. PubMed ID: 29708512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
    Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
    Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on CD4
    Grönberg C; Nilsson J; Wigren M
    Eur J Pharmacol; 2017 Dec; 816():58-66. PubMed ID: 28457923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis.
    Sasaki N; Yamashita T; Kasahara K; Takeda M; Hirata K
    Curr Pharm Des; 2015; 21(9):1107-17. PubMed ID: 25312730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(-/-) mice.
    Zhou J; Dimayuga PC; Zhao X; Yano J; Lio WM; Trinidad P; Honjo T; Cercek B; Shah PK; Chyu KY
    Biochem Biophys Res Commun; 2014 Jan; 443(3):864-70. PubMed ID: 24342615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.
    Cochain C; Zernecke A
    Basic Res Cardiol; 2015; 110(4):34. PubMed ID: 25947006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.